Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Healius Limited ( (AU:HLS) ).
Dimensional Fund Advisors and its related entities have notified Healius that they have ceased to be a substantial holder in the company as of 13 April 2026. The change reflects a reduction in Dimensional’s relevant voting interest below the substantial shareholding threshold, indicating an adjustment in its investment position in the healthcare group and potentially altering the company’s institutional shareholder mix.
No new associates were disclosed in connection with this change, suggesting the move is primarily portfolio-driven rather than the result of any broader corporate alliance shift. The notice, lodged under Australian Corporations Act requirements, provides transparency for investors about movements in significant shareholdings and may prompt market attention to Healius’s evolving ownership structure.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$0.80 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Ltd is an Australian healthcare company operating in the medical services sector. It focuses on providing diagnostic, pathology, and related health services across Australia, serving patients, healthcare practitioners, and institutional clients through a national network of facilities.
Average Trading Volume: 3,434,225
Technical Sentiment Signal: Sell
Current Market Cap: A$370.3M
Find detailed analytics on HLS stock on TipRanks’ Stock Analysis page.